TFA
LUNG icon

Transamerica Financial Advisors’s Pulmonx LUNG Stock Holding History

Transamerica Financial Advisors’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58 Sell
45
-11
-20% -$15 ﹤0.01% 2112
2026
Q1 		$72 Buy
+56
New +$93 ﹤0.01% 1801

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Transamerica Financial Advisors's LUNG Position: Q2 2026 in Review

Transamerica Financial Advisors reduced its Pulmonx (LUNG) stake by 20% in Q2 2026, selling an estimated $15 and leaving 45 shares worth $58. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

Transamerica Financial Advisors first reported a position in LUNG in Q1 2026 and has held it in 2 quarters since. The position peaked at $72 in Q1 2026. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Transamerica Financial Advisors held 45 shares of Pulmonx worth $58 as of Q2 2026.
  • Transamerica Financial Advisors sold 11 Pulmonx shares in Q2 2026, an estimated $15.
  • Pulmonx made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #2112 holding.
  • Transamerica Financial Advisors first reported a position in Pulmonx in Q1 2026 and has held it in 2 quarters since.
  • Transamerica Financial Advisors's Pulmonx position peaked at $72 in Q1 2026.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.